Biocept Inc said it has granted incentive options to 12 new employees to purchase a total of 89,550 shares of common stock. Incentive stock options expire August 31, 2022 and are available to new employees joining Biocept as incentive material pursuant to Nasdaq Listing Rule 5635(c)(4). Induction share options with an exercise price of $1.03 per share on transfer of ownership First anniversary of commencement date vests and the remaining 75% of shares vest in equal monthly installments over the next 36 months, provided the new employee continues with the company Biocept on the relevant transfer date. The forced share options are subject to the terms and conditions of Biosept’s revised and revised 2013 Equity Incentive Plan (Revised).
Bloom Health Partners Inc reported strong revenue growth in its fiscal third quarter, nearly beating its full-year revenue guidance for just three quarters. Bloom CEO Andrew Morton said the company’s third-quarter revenue was CA$8.4 million, bringing its year-to-date total to CA$24.9 million, nearly in line with expected revenue for fiscal 2022 between 25 and 2020. 28 million Canadian dollars. There is a quarter left. “We are proud of our team’s results this year as we continue to build Bloom into an innovative provider of healthcare technology solutions and services for employers,” he said.
Todos Medical Ltd said it has entered into a lease for a 15,200-square-foot herbal supplement manufacturing plant on 6 acres in the Dallas-Fort Worth, Texas area. The facility is equipped with equipment for botanical extraction, distillation and production of finished products, including equipment for botanical production worth $ 2 million. This enables the production of Tollovid, a protease inhibitor-based immune support supplement, as well as other immune support ingredients such as vitamin C and CBD-A.
Broker Stifel GMP is optimistic about Mongolian mining company Steppe Gold Ltd and expects its share price to rise as the company continues to produce solid production at its flagship ATO mine. On August 30, Steppe reported positive progress on the second phase of its mine expansion plan, which is expected to be completed this October following a landmark power agreement and construction of a new stationary crusher. The plant is 72 percent complete and once operational, the new plant will quadruple Steppe’s current processing capacity to 4 million tonnes per annum at 50 percent capacity. Stifel has a Buy recommendation for Steppe shares with a target price of CAD$2.90 per share (current price: CAD$1.10).
PlantX Life Inc has announced the continuation of its successful live events program to support the company’s retail outlets and enhance its growing reputation as a leader in plant-based lifestyles. Last weekend, PlantX said it held events at Peter Rubi’s Montrose Avenue store and XMarket Uptown in Chicago to increase traffic and promote a healthy, plant-based lifestyle. “Last weekend’s live vegan campaign activation was a huge success for PlantX and our brand partners,” PlantX CEO Lorne Rapkin said in a statement. “At both locations in Chicago, we made a noticeable impact on sales of these premium products and increased overall sales across both stores.”
American Manganese Inc, which does business as battery material RecycLiCo, says its advanced battery recycling and refurbishment process can result in lower carbon dioxide equivalent (CO2) emissions from lithium hydroxide monohydrate (LHM) production than traditional methods. The results are presented in the Life Cycle Assessment (LCA) carried out by Minviro Ltd, a UK-based and internationally recognized sustainability and life cycle assessment consultancy. Minviro estimates that for every kilogram of LHM produced, the RecycLiCo process could emit 3.3 kilograms of CO2-eq, well below the 12.7 kilograms of CO2-eq calculated from conventional mining and processing based on industry averages. This means that for every 100,000 new electric vehicle (EV) batteries produced using LHM in the RecycLiCo process, an average of 40,570 tons (approximately the weight of 300 blue whales) of CO2 equivalent emissions can be avoided.
Willow Biosciences Inc has provided an update on cannabidiol (CBG), the first commercial functional ingredient in its portfolio. “As we expand our product portfolio and partnerships, we are also committed to maximizing the value of our first functional ingredient, CBG, through continuous development, operational improvements and marketing efforts,” said Willow Acting President and CEO Dr. Peter Seufer-Wassertal. statement. “We remain optimistic about the future opportunities for CBG and other cannabinoids and will be well positioned to capitalize on this value as the market develops,” he added.
Solstice Gold Corp announced the closing of a previously announced private placement financing with gross proceeds of approximately $2.7 million, higher than previously expected gross proceeds of $1.1 million. The offering issued 12,766,667 HD units at $0.12 per HD unit, each comprising one common share of the company and a warrant exercisable at $0.17 within 18 months from the closing date. units at a price of $0.135 per NFT unit, each unit consists of one common share eligible for shares outstanding (FT) for the purposes of the Canada Income Tax Act, and the terms of the warrant are identical to the semi-warrants in HD units. The company also announced that due to lack of personal time, Kevin Reid will step down as director of the company on September 30, 2022, but will remain the company’s largest shareholder. Under the offer, Reid purchased $1 million worth of HD units at $0.12 per unit, increasing his stake in the company to approximately 16.5%. “Kevin has been a staunch supporter and major shareholder of Solstice since its inception, including serving on the Board of Directors since 2020,” Solstice Chairman David Adamson said in a statement.
Bhang Inc said it is partnering with Hoodie Analytics, one of the largest and most influential cannabis platforms, to optimize its analytics and sales strategy. Hoodie Analytics tracks over 4 million unique listings daily from over 8,500 pharmacies in the US and Canada, and tracks sales metrics such as pricing, promotions, inventory status, distribution, and shelf share. “Complex strategic decisions require more than accurate data for a certain period. We need real-time analytics to understand when and where we can make a difference,” Wes Eder, vice president of global revenue at Bhang, said in a statement.
Ridgeline Minerals Corp provided an update on the company’s ongoing drilling and exploration program at the Selena and Swift projects in Nevada and the Robber Gulch project in Idaho. Mike Harp, Ridgeline’s vice president of exploration, said the company is pleased to complete its massive drilling program at Selena and Swift this fall, with Swift drilling being 100% funded by Nevada Gold Mines partners. “At our wholly owned Selena project, we will continue to discover new mineral deposits as our team takes a systematic approach to exploring this complex CRD system. Selena has shown an incredible exploration advantage and our third drilling campaign in 2022 is an important first step towards expanding our shallow mineralized footprint in several areas as we move the project towards the first resource,” Harp said in a statement.
Mindset Pharma Inc, which is developing new psychedelic and non-psychedelic drugs for the treatment of neuropsychiatric and neurological disorders, has discovered that through its research work, it has identified three more very new, new generation, non-tryptamine-based families of psychedelics. While much of the industry’s focus has been on classic psychedelic drugs, Mindset noted that it has purposefully expanded its research efforts beyond the psilocybin and N,N-dimethyltryptamine (DMT) class of tryptamine drugs. medicines. Using a fragment-based drug discovery (FBDD) approach coupled with a narrowly targeted strategy for medicinal chemistry, scientists at this Toronto-based drug development company designed and developed three new, chemically distinct, tryptamine-free small molecular scaffolds, families 6, 7, and 8. Mindset has filed provisional patent applications for these families and achieved a positive Freedom of Operation (FTO) search result.
Silver Range Resources Ltd has announced that it is preparing to hand over its Bellehelen silver and gold project in central Nevada to a private company in British Columbia, British Columbia. The deal is expected to close within 45 days and the British Columbia company will pay out CAD$300,000 in cash and 200,000 shares over four years. It will also receive 2% Smelter Net Income (NSR), which can be purchased for as little as 1% for C$1 million. Any resource has a commission of $2 per ounce (gold equivalent), which is defined in the asset. The company also has until May 30 next year to complete its listing on the Canadian Stock Exchange.
Adastra Holdings Ltd said it is well positioned for future growth as it received a key controlled drug and substance dealer license on August 24 this year that allows the company to process active compounds derived from the psychedelic mushrooms psilocybin and psilocin. Adastra CEO Michael Forbes said in a statement: “This is another major step forward in the next phase of Adastra’s goal of becoming an alternative botanical for physical and mental health and optimal functioning.” He added, “We believe our distributor license gives Adastra a first-mover advantage over peers in light of any future regulatory changes to our psilocybin extraction and preparation process. Passing pre-qualification allows us to stay one step ahead.”
Aftermath Silver Limited announced impressive final analysis results for its 2021-2022 diamond drilling program at the Berengela silver-copper-manganese deposit in southern Peru. The Vancouver-based company said the program completed 63 wells totaling 6,168 meters (m) of core drilling. The Aftermath engineering team is incorporating the results of the drilling into a revised geological interpretation of the Berengela mineralization, which will be used to complete a new Mineral Resource estimate in accordance with NI 43-101 later in 2022. Historical mapping and resource modeling show that the mineralization extends 1,300 meters along strike, including a 100-meter historic open-pit zone but no drillholes, and a width of 200 to 400 meters, the company said.
As part of a previously announced qualifying agreement, the Tier 1 North American global aerospace company will audit powder production at its Montreal metal powder facility in September, PyroGenesis Canada Inc. said. The company said the audit was part of the final stage of the qualification process, which was scrutinized by clients for more than 18 months. The company said this part of the audit will primarily consist of a site and operations assessment, during which PyroGenesis technicians and operators will demonstrate the reliability of the company’s advanced metal powder manufacturing equipment and work instructions.
Irwin Naturals Inc announced that its subsidiary Irwin Naturals Cannabis, Inc has signed a licensing agreement with 42 Degrees Processing LLC to manufacture and distribute Irwin Naturals THC products in Michigan, one of the nation’s fastest growing cannabis markets. Under the agreement, 42 Degrees Processing will add THC to Irwin Naturals products and supply it to approximately 1,000 dispensaries currently operating in Michigan, the supplement company said. “Michigan is an important step in bringing Irwin Naturals THC products to pharmacy shelves in all 38 states where cannabis has been legal,” said Irwin Naturals CEO Klee Irwin.
American Resources said it has agreed to sell Novusterra Inc. exclusive rights to carbon nanostructures and graphene technology for $16 million in Novusterra shares paid in Class A common stock. In addition, members of American Resources will take over Novusterra’s management and sit on its board of directors. American Resources said it intends to distribute the majority of the shares acquired in the deal to its core investors at or before Novusterra’s public offering, which is still subject to the exchange and SEC approval.
Guardforce AI Co Ltd has announced a series of appointments to form a revamped management team to support its accelerated growth in the robotics and information security markets. First, it stated that CEO Ray (Olivia) Wang had been named chairman of the board while continuing in his current position. She replaced Wing Khai (Terence) Yap, who stepped down to pursue other interests, the company added. Lin Jia, who has led Guardforce’s research and development department since May, has been named president of the company. Previously, he served as COO and CTO at Shenzhen Smart Guard Robot Co., Ltd., a leading robotics company specializing in the development, production and application of service robots in mainland China.
Kontrol Technologies Corp said it has entered into a loan agreement of up to CA$50 million that will streamline its balance sheet and increase opportunities for future acquisitions. The company noted that the lender is a Schedule 1 bank and the line of credit includes a loan of up to $20 million, a revolving line of credit of up to $10 million, and a so-called accordion feature of up to $20 million. “These funds will simplify the balance sheet by consolidating debt and lowering the company’s cost of capital,” Kontrol CEO Paul Ghezzi said in a statement. “It will also add capacity for M&A that provides financial flexibility to allow capital deployment in a timely manner as we execute on potential acquisitions.” “It will also add capacity for M&A that provides financial flexibility to allow capital deployment in a timely manner as we execute on potential acquisitions.” “It will also add M&A opportunities, which will provide financial flexibility to allow timely placement of capital as we pursue potential acquisitions.” “It will also enhance M&A opportunities by providing the financial flexibility to allocate capital on a timely basis as we make potential acquisitions.”
Electric Royalties Ltd said its board of directors has adopted a shareholder rights plan to ensure that all Electric Royalties shareholders are treated fairly in any takeover bid for the company’s outstanding common stock. The plan takes effect immediately and is subject to approval by the company’s shareholders at the annual general meeting in 2022. If approved, the program will run for three years. The plan is similar to the rights plans adopted by other Canadian companies and approved by their shareholders. It is not accepted in response to any specific offer or intent to gain control of the company. The board of the company believes that the plan is beneficial to shareholders if the company operates through a hostile takeover bid, providing more opportunities to protect the interests of all shareholders.
VR Resources Ltd said it has completed the first tranche of a previously announced no-intermediary private placement comprising 6,443,750 shares at 16 cents per share with gross proceeds of $1,031,000. Each unit consists of one share of the company’s common stock and one half of the common stock warrants. Each full warrant entitles the holder to purchase an additional share of common stock within 18 months of the closing date of the funding at a strike price of 25 cents per share of common stock. For funding, the company paid some of the discoverers $11,940 in cash. Securities issued under the financing are subject to a four-month holding period under Canadian securities laws. VR said it will use the net proceeds from funding its mineral exploration business, which includes active exploration for various minerals located in Ontario, Canada, and Nevada, USA.
Nevada Silver Corporation said it has completed a previously announced sale of securities to its wholly owned subsidiary, North Star Manganese Inc (NSM). NSM sold 3,160,233 shares of NSM for $0.25 per share, generating gross proceeds of $790,058.23. As a result of the NSM financing, the number of NSM shares outstanding increased to 33,160,233 NSM shares of common stock, reducing the indirect ownership of the company to approximately 90.5%. NSM funding has received final approval from the TSX Venture Exchange. Proceeds from NSM funding will be used to advance technical research and general working capital for the Emily Manganese project. No commissions or fees are paid in connection with NSM funding.
Think Research Corporation announced that it has awarded 450,000 Restricted Shares (RSU) to key employees of the company as part of its comprehensive equity incentive plan, which will be transferred within one year. Think also announced that on June 22, 2022, it provided 215,960 RSU to certain non-executive directors of the company, which will be transferred on September 1, 2022. In addition, on June 22, 2022, the Company granted 218,531 deferred shares (DSU) to certain non-executive directors of the Company as part of the Comprehensive Equity Incentive Plan. Each DSU represents the right to one share of common stock when the owner of the DSU ceases to be an officer, employee or director of the company or any of its subsidiaries.
Co-Diagnostics Inc has announced that it will have a booth at the upcoming Healthcare Expo Asia 2022 at Marina Bay Sands in Singapore from August 31 to September 2, 2022. The event is the most authoritative healthcare exhibition in Southeast Asia and is expected to host more than 14,000 visitors from 70 countries and regions, and is open to medical experts, company executives in the healthcare industry and other related industry professionals. Co-Diagnostics expects the show to provide company representatives and distributors with the opportunity to introduce Co-Diagnostics products to a wide range of international customers and expand the reach of the company’s distributors in Asia. More information about the conference, including face-to-face and virtual registration, is available at the following link: www.medicalfair-asia.com. Visitors interested in learning more about the company and its products, including its future point-of-care and home-based rapid PCR platforms, can visit booth #2G01.
Zynerba Pharmaceuticals Inc has announced the acceptance of an oral presentation at the 24th International Research Symposium of the Society for the Study of Behavioral Phenotyping (SSBP) to be held September 8-10, 2022 in Oslo, Norway. Oral presentation titled Open Tolerance and Efficacy Trial of ZYN002 (Cannabidiol) Administered as a Transdermal Gel in Children and Adolescents with 22q11.2 Deletion Syndrome (INSPIRE) Due 2022 Delivered September 8 at 15:30 CET time / 9:30 am. ET. Copies of presentation slides will be posted on the Zynerba corporate website at http://zynerba.com/publications/. More information about the meeting is available on the SSBP website https Found at ://ssbp.org.uk/.
Numinus Wellness Inc has announced that it will be attending the 24th Annual HC Wainwright Global Investment Conference taking place September 12-14, 2022 at the Lotte New York Palace Hotel in New York City. Numinus will be in attendance Tuesday, September 13, 2022 at 9:00 AM ET. Those interested can register for the event at the following link: https://hcwevents.com/annualconference/. For more information about the meeting, or to schedule a face-to-face meeting with Numinus management, interested parties may email the KCSA Strategic Communications at numinusir@kcsa.com.
Vyant Bio Inc has announced that it will be speaking at the 24th Annual HC Wainwright Global Investment Conference. The event will take place from 12 to 14 September 2022. In the presentation, Jay Roberts, CEO of Vyant Bio, will discuss key scientific, commercial and strategic milestones and achievements. Registered members have on-demand access to recorded presentations (24×7) for 90 days. Institutional investors wishing to hear the company’s presentations can follow the link https://hcwevents.com/annualconference/ to register for the conference. Once registration is confirmed, attendees will be able to request a face-to-face meeting with the company through the meeting website. Vyant Bio will also host a 1:1 external meeting in New York during and after the HC Wainwright Global Investment Conference and interested parties can contact Scott Powell at info@skylineccg.com or at (646) 893-5835 x2. . Presentation slides will also be available on the investor section of the Vyant Bio website.
OTC Markets Group Inc, operator of 12,000 US and international regulated securities markets, has announced that Irish digital therapy company HealthBeacon PLC is eligible to trade on the OTCQX Best Market and begins trading today under the symbol HBCNF. The transition to the OTCQX market is an important step for companies seeking to provide transparent trading for their US investors. For companies listed on qualified international exchanges, simplified market standards allow them to use domestic market reports to provide information in the United States. To qualify for OTCQX, companies must meet high financial standards, follow best corporate governance practices, and demonstrate compliance with applicable securities laws. “We are excited to begin trading on the OTCQX market, which is a significant milestone for HealthBeacon and an opportunity to expand our U.S. investor base,” said HealthBeacon CEO and co-founder Jim Joyce. “Fundamentally, this development increases the visibility and exposure of our shares in one of our core markets, but we also believe it will provide better liquidity, which will increase shareholder value. HealthBeacon’s mission is to become the world’s leading digital therapeutic platform for injectable medicines. This is another step for us as a public company to help people improve their health through sustainable digital solutions.”
OTC Markets Group Inc, operator of 12,000 regulated markets for US and international securities, announced that Montage Gold Corp, an Ivory Coast gold exploration and production company, has been awarded the right to trade on top OTCQX markets, boosted today from Pink Markets . MAUTF code. The transition to the OTCQX market is an important step for companies seeking to provide transparent trading for their US investors. For companies listed on qualified international exchanges, simplified market standards allow them to use domestic market reports to provide information in the United States. To qualify for OTCQX, companies must meet high financial standards, follow best corporate governance practices, and demonstrate compliance with applicable securities laws.
OTC Markets Group Inc, operator of 12,000 regulated US and international securities markets, has announced that POSaBIT Systems Corporation, a payment infrastructure provider for the cannabis industry, is eligible to trade on OTCQX’s premier marketplace, updated today with OTCQB Venture. POSAF market symbol. The OTCQX Market provides investors with a quality US public market for researching and trading the shares of investor-focused companies. The entry into the OTCQX market is an important milestone for the company, allowing it to showcase its expertise and raise awareness among US investors. To qualify for the OTCQX, companies must meet high financial standards, follow best corporate governance practices, and demonstrate compliance with applicable securities laws.
Proactive Investors Australia Pty Ltd ACN 132 787 654 (the company, we or we) provides you with access to the above, including any news, quotes, information, data, texts, reports, ratings, opinions,…
Michael O’Shea introduced Proactive to Xcelerate Inc (OTCQB:XCRT), which seeks to acquire rather than develop its technology and medical services. Having a respected team of engineers who discover technologies in non-medical fields and untapped applications in medical technology…
Market Indices, Commodities and Regulatory Headlines Copyright © Morningstar. Unless otherwise specified, data is delayed by 15 minutes. Operating conditions.
This website uses cookies so that we can provide you with the best user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping us understand which parts of the website you find most interesting and useful. For more information, please see our Cookie Policy.
These cookies are used to deliver our website and content. Strictly necessary cookies are specific to our hosting environment, while functional cookies are used to facilitate social login, social media sharing and multimedia content embedding.
Advertising cookies collect information about your browsing habits, such as the pages you visit and the links you follow. This audience data is used to make our website more relevant.
Performance cookies collect anonymous information and are intended to help us improve our website and meet the needs of our audience. We use this information to make our website faster, more up-to-date and improve navigation for all users.